Orphan Neuro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody.

Kath gallagherSarah boyceCompany contactHealth care conferencePrnewswire avidity biosciences incCorporate panel discussionAvidity biosciences incAntibody oligonucleotide conjugatesAnnual global healthcareAnnual health carePanel discussionOrphan neuroAnnual healthcareOligonucleotide conjugatesAvidity biosciencesHealth care amp hospitals